AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32721237 — intervention group
Group type: COMPARATOR
Intervention: Curettage-Electrodesiccation
Number of subjects: 117
Study 35246497 — intervention group
Group type: EXPERIMENTAL
Intervention: Intelligent volume‐assured pressure support (iVAPS)
Number of subjects: 30
Study 35246497 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous/timed (S/T)
Number of subjects: 30
Study 32586434 — intervention group
Group type: EXPERIMENTAL
Intervention: Be a Mom (self-guided web-based intervention grounded in cognitive behavioral therapy)
Number of subjects: 194
Study 32586434 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 194
Study 35645331 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led Adverse Drug Reaction (ADRe) Profile
Number of subjects: 60
Study 35645331 — intervention group
Group type: COMPARATOR
Intervention: Usual standard care
Number of subjects: 60
Study 32647054 — intervention group
Group type: EXPERIMENTAL
Intervention: Lixisenatide
Number of subjects: 57
Study 32647054 — intervention group
Group type: COMPARATOR
Intervention: Liraglutide
Number of subjects: 57
Study 32647054 — intervention group
Group type: EXPERIMENTAL
Intervention: Lixisenatide and Liraglutide
Number of subjects: 57
Study 35165906 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 0
Study 35165906 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 0
Study 34869486 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxybutyl chitosan (HBC) injection
Number of subjects: 50
Study 34869486 — intervention group
Group type: COMPARATOR
Intervention: VisiPlug absorbable intracanalicular plug
Number of subjects: 50
Study 36790876 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventional program for promoting nurses' resilience
Number of subjects: 0
Study 33772570 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 20
Study 33772570 — intervention group
Group type: COMPARATOR
Intervention: Conventional rotary instruments
Number of subjects: 20
Study 32526849 — intervention group
Group type: EXPERIMENTAL
Intervention: Transference work (TW) in psychodynamic psychotherapy
Number of subjects: 0
Study 32526849 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 34525734 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradient Boosting Algorithm (GBM) for drought prediction
Number of subjects: 0
Study 34525734 — intervention group
Group type: EXPERIMENTAL
Intervention: Normalized Difference Water Index (NDWI‐7)
Number of subjects: 0
Study 34525734 — intervention group
Group type: EXPERIMENTAL
Intervention: Snow Cover Fraction (SCF)
Number of subjects: 0
Study 34525734 — intervention group
Group type: EXPERIMENTAL
Intervention: Extremely Randomized Trees (ERT)
Number of subjects: 0
Study 34525734 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta‐Gaussian model
Number of subjects: 0
Study 34525734 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme drought and hot conditions
Number of subjects: 0
Study 34525734 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme hot conditions
Number of subjects: 0
Study 33885930 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 PUFA treatment for 24 weeks
Number of subjects: 142
Study 33885930 — intervention group
Group type: COMPARATOR
Intervention: Healthy individuals
Number of subjects: 142
Study 34605142 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra rapid lispro (URLi)
Number of subjects: 0
Study 34605142 — intervention group
Group type: COMPARATOR
Intervention: Humalog
Number of subjects: 0
Study 32049789 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulinastatin (UTI)
Number of subjects: 75
Study 32049789 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhubarb
Number of subjects: 75
Study 32049789 — intervention group
Group type: EXPERIMENTAL
Intervention: UTI plus Rhubarb
Number of subjects: 75
Study 32049789 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study 33126317 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoiesis-stimulating agents (ESAs) combined with traditional Chinese medicine (TCM)
Number of subjects: 0
Study 33126317 — intervention group
Group type: COMPARATOR
Intervention: Erythropoiesis-stimulating agents (ESAs)
Number of subjects: 0
Study 33751003 — intervention group
Group type: EXPERIMENTAL
Intervention: TRIOS 3
Number of subjects: 11
Study 33751003 — intervention group
Group type: EXPERIMENTAL
Intervention: CS 3600
Number of subjects: 11
Study 33751003 — intervention group
Group type: EXPERIMENTAL
Intervention: Emerald S
Number of subjects: 11
Study 33751003 — intervention group
Group type: EXPERIMENTAL
Intervention: Full metal crown
Number of subjects: 11
Study 33751003 — intervention group
Group type: EXPERIMENTAL
Intervention: High-translucency substrate group
Number of subjects: 11
Study 33751003 — intervention group
Group type: EXPERIMENTAL
Intervention: Polished and unpolished class II amalgam restorations
Number of subjects: 11
Study 33751003 — intervention group
Group type: EXPERIMENTAL
Intervention: All three scanners
Number of subjects: 11
Study 34455218 — intervention group
Group type: EXPERIMENTAL
Intervention: Origanum majorana tea
Number of subjects: 60
Study 34455218 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34786698 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital voice recorder app
Number of subjects: 52
Study 34786698 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder app
Number of subjects: 52
Study 34786698 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimenter-assigned tasks
Number of subjects: 52
Study 34786698 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital recorder or reminder app usage
Number of subjects: 52
Study 33561514 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal relative deprivation (PRD) group
Number of subjects: 48
Study 33561514 — intervention group
Group type: COMPARATOR
Intervention: Non-PRD group
Number of subjects: 48
Study 33184743 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin (0.143 mg/kg)
Number of subjects: 10
Study 33184743 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 35364250 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine
Number of subjects: 0
Study 35364250 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35364250 — intervention group
Group type: COMPARATOR
Intervention: Active-control
Number of subjects: 0
Study 32332672 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous adductor canal block (CACB) with 0.5% ropivacaine 20 mL followed by continuous infusion of 0.2% ropivacaine at 5 mL/h for 48 hours
Number of subjects: 60
Study 32332672 — intervention group
Group type: COMPARATOR
Intervention: Single‐injection adductor canal block (SACB) with 0.5% ropivacaine 20 mL
Number of subjects: 60
Study 32332672 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous adductor canal block (CACB)
Number of subjects: 60
Study 32332672 — intervention group
Group type: COMPARATOR
Intervention: Single‐injection adductor canal block (SACB)
Number of subjects: 60
Study 34003071 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (500 mg capsule, 1 hour before)
Number of subjects: 14
Study 34003071 — intervention group
Group type: COMPARATOR
Intervention: Placebo (cellulose capsule, 1 hour before)
Number of subjects: 14
Study 37941802 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-µg/dose vaccine
Number of subjects: 135
Study 37941802 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-µg/dose vaccine
Number of subjects: 135
Study 37941802 — intervention group
Group type: COMPARATOR
Intervention: Placebo (adjuvant only)
Number of subjects: 135
Study 33045915 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional status assessment using anthropometric measurements and WHO Anthro software
Number of subjects: 408
Study 33045915 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index measurements of mothers
Number of subjects: 408
Study 33045915 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of metabolic risk in mothers
Number of subjects: 408
Study 32470515 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 102
Study 32470515 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 102
Study 36216204 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam (Group R)
Number of subjects: 40
Study 32955164 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 IU·kg bw−1 rhEpo injections every second day for 3 weeks during exposure at sea level
Number of subjects: 73
Study 32955164 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 IU·kg bw−1 rhEpo injections every second day for 3 weeks during exposure at altitude
Number of subjects: 73
Study 32955164 — intervention group
Group type: COMPARATOR
Intervention: Placebo injections at sea level
Number of subjects: 73
Study 32955164 — intervention group
Group type: COMPARATOR
Intervention: Placebo injections at altitude
Number of subjects: 73
Study 32933339 — intervention group
Group type: EXPERIMENTAL
Intervention: t‐year event rate
Number of subjects: 69
Study 32933339 — intervention group
Group type: EXPERIMENTAL
Intervention: restricted mean survival time with fixed τ
Number of subjects: 69
Study 32933339 — intervention group
Group type: EXPERIMENTAL
Intervention: generalized Wilcoxon, maximum of test statistics from multiple weighted log‐rank tests, difference in t‐year event rate, difference in restricted mean survival time with fixed and adaptive τ
Number of subjects: 69
Study 32933339 — intervention group
Group type: EXPERIMENTAL
Intervention: various tests investigated
Number of subjects: 69
Study 36229489 — intervention group
Group type: EXPERIMENTAL
Intervention: Birdsong high diversity soundscape
Number of subjects: 295
Study 36229489 — intervention group
Group type: EXPERIMENTAL
Intervention: Birdsong low diversity soundscape
Number of subjects: 295
Study 36229489 — intervention group
Group type: COMPARATOR
Intervention: Traffic noise low diversity soundscape
Number of subjects: 295
Study 36229489 — intervention group
Group type: COMPARATOR
Intervention: Traffic noise high diversity soundscape
Number of subjects: 295
Study 33845615 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine capsular closure
Number of subjects: 116
Study 33845615 — intervention group
Group type: COMPARATOR
Intervention: Unrepaired capsulotomy (control group)
Number of subjects: 116
Study 32379479 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate to vigorous intensity interval exercise program (30 minutes, 3 days per week for 8 weeks)
Number of subjects: 28
Study 32379479 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 28
Study 36251544 — intervention group
Group type: EXPERIMENTAL
Intervention: SDF (17% Silver Diamine Fluoride)
Number of subjects: 0
Study 36251544 — intervention group
Group type: EXPERIMENTAL
Intervention: SDF-KI (Silver Diamine Fluoride with Potassium Iodide)
Number of subjects: 0
Study 36251544 — intervention group
Group type: EXPERIMENTAL
Intervention: RV-SDF (Riva Star)
Number of subjects: 0
Study 36251544 — intervention group
Group type: EXPERIMENTAL
Intervention: RV-SDFKI (Riva Star with Potassium Iodide)
Number of subjects: 0
Study 36251544 — intervention group
Group type: COMPARATOR
Intervention: Control groups (not specified)
Number of subjects: 0
Study 36251544 — intervention group
Group type: EXPERIMENTAL
Intervention: SDF
Number of subjects: 0
Study 36251544 — intervention group
Group type: EXPERIMENTAL
Intervention: SDF-KI
Number of subjects: 0
Study 36251544 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment groups (SDF, SDF-KI, RV-SDF, RV-SDFKI)
Number of subjects: 0
Study 32938633 — intervention group
Group type: EXPERIMENTAL
Intervention: Opportunistic screening (pulse palpation, electronic blood pressure measurement with atrial fibrillation algorithm, ECG with handheld device)
Number of subjects: 18744
Study 32938633 — intervention group
Group type: EXPERIMENTAL
Intervention: Opportunistic screening (12 lead ECG)
Number of subjects: 18744
Study 32938633 — intervention group
Group type: EXPERIMENTAL
Intervention: Holter monitoring
Number of subjects: 18744
Study 32938633 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 18744
Study 33287617 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical stressor (4 × 6‐s bike sprints) on D14
Number of subjects: 30
Study 33287617 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological stressor (5 × 2‐min cognitive tests with social evaluation) on D14
Number of subjects: 30
Study 33287617 — intervention group
Group type: COMPARATOR
Intervention: Physical stressor on D7
Number of subjects: 30
Study 33287617 — intervention group
Group type: COMPARATOR
Intervention: Physical stressor on D21
Number of subjects: 30
Study 33287617 — intervention group
Group type: COMPARATOR
Intervention: Psychological stressor on D7
Number of subjects: 30
Study 33287617 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological stressor on D14
Number of subjects: 30
Study 33287617 — intervention group
Group type: COMPARATOR
Intervention: Psychological stressor on D21
Number of subjects: 30
Study 33130414 — intervention group
Group type: COMPARATOR
Intervention: Higher school-level value-added education (VAE)
Number of subjects: 3337
Study 33130414 — intervention group
Group type: COMPARATOR
Intervention: Higher overall levels of commitment and belonging
Number of subjects: 3337
Study 33130414 — intervention group
Group type: COMPARATOR
Intervention: Stronger personal commitment to learning and teacher relationships
Number of subjects: 3337
Study 33130414 — intervention group
Group type: COMPARATOR
Intervention: Participation and contraception use
Number of subjects: 3337
Study 34405256 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-day subcutaneous GIP infusion (6 pmol kg-1 min-1)
Number of subjects: 20
Study 34405256 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline [154 mmol/l NaCl])
Number of subjects: 20
Study 33177712 — intervention group
Group type: EXPERIMENTAL
Intervention: Bread intervention
Number of subjects: 491
Study 34954841 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg 2 ml autoinjector (AI)
Number of subjects: 0
Study 34954841 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 2× 1 ml prefilled syringe (PFS)
Number of subjects: 0
Study 34954841 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34954841 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg 2 ml AI
Number of subjects: 0
Study 33551234 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant treatment
Number of subjects: 71
Study 35306231 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiation therapy (SBRT) after multiagent chemotherapy (MA‐CTX)
Number of subjects: 44
Study 32314472 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial replacement concentrate Ⅱ (PRC II, 50% corn + 22.5% cassava residue + 22.5% DDGS)
Number of subjects: 30
Study 32314472 — intervention group
Group type: COMPARATOR
Intervention: Typical concentrate (TC, 65% corn + 15% wheat bran + 15% soybean meal)
Number of subjects: 30
Study 32314472 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial replacement concentrate Ⅰ (PRC I, 50% corn + 22.5% corn gluten + 22.5% PKC)
Number of subjects: 30
Study 36007339 — intervention group
Group type: COMPARATOR
Intervention: Satralizumab in combination with baseline immunosuppressive therapy (IST)
Number of subjects: 75
Study 36007339 — intervention group
Group type: COMPARATOR
Intervention: Satralizumab monotherapy
Number of subjects: 75
Study 36007339 — intervention group
Group type: EXPERIMENTAL
Intervention: Satralizumab
Number of subjects: 75
Study 34478788 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium nitrate in polycarboxylate cement
Number of subjects: 48
Study 34478788 — intervention group
Group type: COMPARATOR
Intervention: Mineral trioxide aggregate (MTA)
Number of subjects: 48
Study 32933571 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded activity and pain education (GAPE)
Number of subjects: 144
Study 32933571 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 144
Study 34645366 — intervention group
Group type: EXPERIMENTAL
Intervention: BFR group
Number of subjects: 42
Study 34645366 — intervention group
Group type: EXPERIMENTAL
Intervention: BFR + MI group
Number of subjects: 42
Study 34645366 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 42
Study 32524338 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-P10
Number of subjects: 51
Study 32524338 — intervention group
Group type: COMPARATOR
Intervention: RTX originator
Number of subjects: 51
Study 35682148 — intervention group
Group type: EXPERIMENTAL
Intervention: Copenhagen adduction exercise (CAE) for 8 weeks
Number of subjects: 45
Study 35682148 — intervention group
Group type: COMPARATOR
Intervention: Control group with no intervention
Number of subjects: 45
Study 32813947 — intervention group
Group type: EXPERIMENTAL
Intervention: Evinacumab (15 mg/kg every 4 weeks)
Number of subjects: 65
Study 32813947 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 32813947 — intervention group
Group type: EXPERIMENTAL
Intervention: Evinacumab
Number of subjects: 65
Study 32969535 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD)
Number of subjects: 8
Study 32969535 — intervention group
Group type: COMPARATOR
Intervention: Habitual diet (HD)
Number of subjects: 8
Study 34378320 — intervention group
Group type: EXPERIMENTAL
Intervention: App group (10 min app-guided mindfulness for 4 weeks)
Number of subjects: 148
Study 34378320 — intervention group
Group type: COMPARATOR
Intervention: Wait to Treat group (received the same intervention after initial wait)
Number of subjects: 148
Study 34334440 — intervention group
Group type: EXPERIMENTAL
Intervention: Teenage workers (both genders)
Number of subjects: 2800
Study 34334440 — intervention group
Group type: EXPERIMENTAL
Intervention: Boys
Number of subjects: 2800
Study 34334440 — intervention group
Group type: EXPERIMENTAL
Intervention: Girls
Number of subjects: 2800
Study 32682397 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Fio2 (0.4)
Number of subjects: 90
Study 32682397 — intervention group
Group type: EXPERIMENTAL
Intervention: High Fio2 (1.0)
Number of subjects: 90
Study 32682397 — intervention group
Group type: COMPARATOR
Intervention: Intra- and postoperative Pao2 to Fio2 ratio
Number of subjects: 90
Study 32682397 — intervention group
Group type: COMPARATOR
Intervention: Postoperative pulmonary complications
Number of subjects: 90
Study 35354325 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacotherapy treatments
Number of subjects: 665
Study 33957878 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 180
Study 33957878 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180
Study 33957878 — intervention group
Group type: COMPARATOR
Intervention: Boys in both groups
Number of subjects: 180
Study 32776173 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (1.5 mA, 20 min)
Number of subjects: 28
Study 32776173 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 28
Study 35465275 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin 2 g 30-60 min before incision (Group A)
Number of subjects: 200
Study 35465275 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin 2 g 30-60 min before incision and Tinidazole 1.6 g 60-120 min before incision (Group B)
Number of subjects: 200
Study 34106582 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural play therapy (CBPT)
Number of subjects: 178
Study 34106582 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 178
Study 36339275 — intervention group
Group type: EXPERIMENTAL
Intervention: Inositol
Number of subjects: 0
Study 36339275 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment of omega-3 fatty acids and inositol
Number of subjects: 0
Study 36339275 — intervention group
Group type: COMPARATOR
Intervention: Omega-3 fatty acids
Number of subjects: 0
Study 32246106 — intervention group
Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training (HIIT) for 8 weeks
Number of subjects: 30
Study 32246106 — intervention group
Group type: COMPARATOR
Intervention: Control (CON) group for 8 weeks
Number of subjects: 30
Study 34080238 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoral optical scanning (IOS)
Number of subjects: 32
Study 34080238 — intervention group
Group type: COMPARATOR
Intervention: Conventional impressions (polyether)
Number of subjects: 32
Study 35324094 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR 50‐300 mg/d
Number of subjects: 76
Study 35324094 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 32743900 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality Salience (MS)
Number of subjects: 358
Study 32743900 — intervention group
Group type: EXPERIMENTAL
Intervention: Terror news (Muslims attacking non-Muslims)
Number of subjects: 358
Study 34116394 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol supplementation (1000 IU/d)
Number of subjects: 44
Study 34116394 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sunflower oil)
Number of subjects: 44
Study 33404048 — intervention group
Group type: EXPERIMENTAL
Intervention: hJAM (hierarchical joint analysis model)
Number of subjects: 0
Study 33404048 — intervention group
Group type: EXPERIMENTAL
Intervention: hJAM
Number of subjects: 0
Study 35750013 — intervention group
Group type: EXPERIMENTAL
Intervention: Comic-based intervention
Number of subjects: 2400
Study 35750013 — intervention group
Group type: COMPARATOR
Intervention: Lessons-as-usual (control)
Number of subjects: 2400
Study 32070779 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal intubation (ETI)
Number of subjects: 967
Study 32070779 — intervention group
Group type: COMPARATOR
Intervention: Supraglottic airway (SGA) insertion
Number of subjects: 967
Study 32227431 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised decoupling protocol
Number of subjects: 1
Study 32227431 — intervention group
Group type: COMPARATOR
Intervention: Conventional decoupling and HRT
Number of subjects: 1
Study 35838110 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin and clavulanate potassium suspension (200 mg/28.5 mg) under fasting conditions
Number of subjects: 24
Study 35838110 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin and clavulanate potassium suspension (200 mg/28.5 mg) under postprandial conditions
Number of subjects: 24
Study 33001268 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance care planning (ACP) conversations
Number of subjects: 15